sbPCI enables high-throughput, cost-effective identification of
donor-specific formulations for T-cell expansion that outperform industry standards
Authors: Jinchun Wang, Siddharth Subham, Andres Campos, Ayomide Oloyede, Vanessa Garapola, Colleen M O’Connor, Andries Zijlstra
StimulusBio at the Society of Immunotherapy of Cancer (SITC) on Nov. 5-9, 2025
in National Harbor, MD
Download the Full Poster Below
Contact StimulusBio to Talk About Your Scientific and Commercial Product Needs
In the competitive landscape of life science tools and diagnostics, even groundbreaking innovations struggle to gain traction and achieve widespread adoption. At StimulusBio, we specialize in empowering these vital technologies to reach their full potential. With our proven commercialization strategies and deep industry expertise, we partner with you at every stage to optimize your product’s marketability, reliability, and profitability – setting you up for lasting success in the marketplace.
